On ECHEMI
Home > Drugs > Voriconazole Registered Holders
Voriconazole structure

Voriconazole structure

Voriconazole

Cyrstalline SolidVoriconazole was introduced in the US for the treatment of acute invasive aspergillosis, candidosis and other emerging fungal infections seen in immuno compromised patients. It can be synthesized in 3 steps by reaction of readily available 6-( 1 -bromoethyl)-4-chloro-5 fluoropyrimidine with I-(2,4-difluorophenyl)-2-(1,2,4-triazol-I-yl) ethanone in the presence of zinc metal. The resulting racemic mixture was submitted to a reductive dechlorination step followed by resoluti

Find 57 Related Holders

INNOVARE LABS PRIVATE LTD
United States United States

API Registration Country

API Active
CHROMO LABORATORIES INDIA PRIVATE LTD
United States United States

API Registration Country

API Active
PHARMATHEN SA
United States United States

API Registration Country

API Active
MAITHRI DRUGS PRIVATE LTD
United States United States

API Registration Country

API Active
LEE PHARMA LTD
United States United States

API Registration Country

API Active
JUBILANT BIOSYS LTD
United States United States

API Registration Country

API Active
ALIVUS LIFE SCIENCES LTD
United States United States

API Registration Country

API Active
MATRIX PHARMACORP PRIVATE LTD
United States United States

API Registration Country

API Active
APITORIA PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
HETERO LABS LIMITED
India India

API Registration Country

API Active
  • Founded in:

    1989-03-10 00:00:00
  • Country:

    India India
  • Address:

    #7-2-A2, Industrial Estate, Sanath Nagar, Sanathnagar I E Balanagar Hyderabad TG 500018 IN
  • Registered Funds:

    2.8 billion INR
  • Email:

Recommended Suppliers of Voriconazole
View 179 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.